Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Dyer

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Alzheimer'S Research & Therapy|August 19, 2024
Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassayAdam H Dyer, Helena Dolphin, Antoinette O'Connor, et al.
International Journal of Molecular Sciences|May 25, 2024
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and VaccinationEmma J Leacy, Jia Wei Teh, Aoife M O'Rourke, et al.
Frontiers in Immunology|April 17, 2023
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19Heike C Hawerkamp, Adam H Dyer, Neha D Patil, et al.
Heliyon|April 7, 2022
Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progressionLiam Townsend, Adam H Dyer, Aifric Naughton, et al.
JCI Insight|February 10, 2026
IFN-γ-induced trained immunity enhances killing of priority pathogens in healthy and genetically vulnerable individualsDearbhla M Murphy, Isabella Batten, Aoife O'Farrell, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Alzheimer'S Research & Therapy|August 19, 2024
Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassayAdam H Dyer, Helena Dolphin, Antoinette O'Connor, et al.
International Journal of Molecular Sciences|May 25, 2024
Effect of Immunosuppression on the Immune Response to SARS-CoV-2 Infection and VaccinationEmma J Leacy, Jia Wei Teh, Aoife M O'Rourke, et al.
Frontiers in Immunology|April 17, 2023
Characterisation of the pro-inflammatory cytokine signature in severe COVID-19Heike C Hawerkamp, Adam H Dyer, Neha D Patil, et al.
Heliyon|April 7, 2022
Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progressionLiam Townsend, Adam H Dyer, Aifric Naughton, et al.
JCI Insight|February 10, 2026
IFN-γ-induced trained immunity enhances killing of priority pathogens in healthy and genetically vulnerable individualsDearbhla M Murphy, Isabella Batten, Aoife O'Farrell, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Pageof 18